Bladder reconstruction: The past, present and future (Review)
- Authors:
- Omar M.S. El‑Taji
- Altaf Q. Khattak
- Syed A. Hussain
-
Affiliations: Department of Surgical Oncology, Royal Liverpool University Hospital, Liverpool L7 8XP, UK, Department of Urology, St. Helen's & Knowsley NHS Teaching Hospitals, University of Liverpool, Prescot L35 5DR, UK, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool L69 3GA, UK - Published online on: April 28, 2015 https://doi.org/10.3892/ol.2015.3161
- Pages: 3-10
This article is mentioned in:
Abstract
Walters MD and Weber AM: Anatomy of the lower urinary tract, rectum and pelvic floor. In: Urogynecology and Pelvic Reconstructive SurgeryWalters MD and Karram MM: 2nd. Mosby, St. Louis, MO: pp. 3–13. 2000 | |
Cancer Research UK, . Bladder Cancer Survival Statistics. https://www.cancerresearchuk.org/cancer-info/cancerstats/?=5441Accessed. April 10–2015 | |
BMJ, . Best practise: Epidemiology. http://bestpractice.bmj.com/best-practice/monograph/980/basics/epidemiology.htmlAccessed. April 11–2015 | |
Cancer Research UK, . Types of bladder cancer. http://cancerhelp.cancerresearchuk.org/type/bladder-cancer/about/types-of-bladder-cancer#spreadAccessed. April 11–2015 | |
Witjes JA, Compérat E, Cowan NC, et al: EAU guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2013 guidelines. Eur Urol. 65:778–792. 2014. View Article : Google Scholar : PubMed/NCBI | |
Sievert KD, Amend B, Nagele U, Schilling D, Bedke J, Horstmann M, Hennenlotter J, Kruck S and Stenzl A: Economic aspects of bladder cancer: What are the benefits and costs? World J Urol. 27:295–300. 2009. View Article : Google Scholar : PubMed/NCBI | |
Lee RK, Abol-Enein H, Artibani W, et al: Urinary diversion after radical cystectomy for bladder cancer: Options, patient selection, and outcomes. BJU Int. 113:11–23. 2014. View Article : Google Scholar : PubMed/NCBI | |
Hautmann S, Felix-Chun KH, Currlin E, et al: Cystectomy for indications other than bladder cancer. Urologe A. 43:172–177. 2004.(In German). PubMed/NCBI | |
Evans B, Montie JE and Gilbert SM: Incontinent or continent urinary diversion: How to make the right choice. Curr Opin Urol. 20:421–425. 2010. View Article : Google Scholar : PubMed/NCBI | |
Westney OL: The neurogenic bladder and incontinent urinary diversion. Urol Clin North Am. 37:581–592. 2010. View Article : Google Scholar : PubMed/NCBI | |
Andersen AV, Granlund P, Schultz A, Talseth T, Hedlund H and Frich L: Long-term experience with surgical treatment of selected patients with bladder pain syndrome/interstitial cystitis. Scand J Urol Nephrol. 46:284–289. 2012. View Article : Google Scholar : PubMed/NCBI | |
Poole-Wilson DS and Barnard RJ: Total cystectomy for bladder tumours. Br J Urol. 43:16–24. 1971. View Article : Google Scholar : PubMed/NCBI | |
Cody JD, Nabi G, Dublin N, McClinton S, Neal DE, Pickard R and Yong SM: Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. Cochrane Database Syst Rev. 15:CD0033062012. | |
Parekh DJ and Donat SM: Urinary diversion: Options, patient selection, and outcomes. Semin Oncol. 34:98–109. 2007. View Article : Google Scholar : PubMed/NCBI | |
Basic DT, Hadzi-Djokic J and Ignjatovic I: The history of urinary diversion. Acta Chir Iugosl. 54:9–17. 2007. View Article : Google Scholar | |
Neuhof H: Facial transplantation into visceral defects: An experimental and clinical study. Surg Gynecol Obstet. 25:3831917. | |
Moon A, Vasdev N and Thorpe AC: Continent urinary diversion. Indian J Urol. 29:303–309. 2013. View Article : Google Scholar : PubMed/NCBI | |
Stein JP, Lieskovsky G, Cote R, et al: Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol. 19:666–675. 2001.PubMed/NCBI | |
Mills RD and Studer UE: Metabolic consequences of continent urinary diversion. J Urol. 161:1057–1066. 1999. View Article : Google Scholar : PubMed/NCBI | |
Shimko MS, Tollefson MK, Umbreit EC, Farmer SA, Blute ML and Frank I: Long-term complications of conduit urinary diversion. J Urol. 185:562–567. 2011. View Article : Google Scholar : PubMed/NCBI | |
Hautmann RE: Urinary diversion: Ileal conduit to neobladder. J Urol. 169:834–842. 2003. View Article : Google Scholar : PubMed/NCBI | |
Hyndman ME, Kaye D, Field NC, et al: The use of regenerative medicine in the management of invasive bladder cancer. Adv Urol. 2012:6536522012.PubMed/NCBI | |
Hussain SA, Moffitt DD, Glaholm JG, Peake D, Wallace DM and James ND: A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer. Ann Oncol. 12:929–935. 2001. View Article : Google Scholar : PubMed/NCBI | |
Harker WG, Meyers FJ, Freiha FS, Palmer JM, Shortliffe LD, Hannigan JF, McWhirter KM and Torti FM: Cisplatin, methotrexate, and vinblastine (CMV): An effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study. J Clin Oncol. 3:1463–1470. 1985.PubMed/NCBI | |
Sternberg CN, Yagoda A, Scher HI, et al: Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol. 133:403–407. 1985.PubMed/NCBI | |
Saxman SB, Propert KJ, Einhorn LH, Crawford ED, Tannock I, Raghavan D, Loehrer PJ Sr and Trump D: Long-term follow up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: A cooperative group study. J Clin Oncol. 15:2564–2569. 1997.PubMed/NCBI | |
Waxman J and Barton C: Carboplatin-based chemotherapy for bladder cancer. Cancer Treat Rev. 19(Suppl C): S21–S25. 1993. | |
Stewart DJ: Mechanisms of resistance to cisplatin and carboplatin. Crit Rev Oncol Hematol. 63:12–31. 2007. View Article : Google Scholar : PubMed/NCBI | |
Hussain SA, Stocken DD, Riley P, et al: A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer. Br J Cancer. 91:844–849. 2004.PubMed/NCBI | |
James ND, Hussain SA, Hall E, et al: BC2001 Investigators: Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med. 366:1477–1488. 2012. View Article : Google Scholar : PubMed/NCBI | |
Atala A: Tissue engineering for bladder substitution. World J Urol. 18:364–370. 2000. View Article : Google Scholar : PubMed/NCBI | |
Atala A, Bauer SB, Soker S, Yoo JJ and Retik AB: Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet. 367:1241–1246. 2006. View Article : Google Scholar : PubMed/NCBI | |
Aboushwareb T, McKenzie P, Wezel F, Southgate J and Badlani G: Is tissue engineering and biomaterials the future for lower urinary tract dysfunction (LUTD)/pelvic organ prolapse (POP)? Neurourol Urodyn. 30:775–782. 2011. View Article : Google Scholar : PubMed/NCBI | |
Baskin LS, Sutherland RS, Thomson AA, Nguyen HT, Morgan DM, Hayward SW, Hom YK, DiSandro M and Cunha GR: Growth factors in bladder wound healing. J Urol. 157:2388–2395. 1997. View Article : Google Scholar : PubMed/NCBI | |
Korossis S, Bolland F, Ingham E, Fisher J, Kearney J and Southgate J: Review: Tissue engineering of the urinary bladder: considering structure-function relationships and the role of mechanotransduction. Tissue Eng. 12:635–644. 2006. View Article : Google Scholar : PubMed/NCBI | |
Petrovic V, Stankovic J and Stefanovic V: Tissue engineering of the urinary bladder: Current concepts and future perspectives. ScientificWorldJournal. 11:1479–1488. 2011. View Article : Google Scholar : PubMed/NCBI | |
Shokeir AA, Harraz AM and El-Din AB: Tissue engineering and stem cells: Basic principles and applications in urology. Int J Urol. 17:964–973. 2010. View Article : Google Scholar : PubMed/NCBI | |
Wood D and Southgate J: Current status of tissue engineering in urology. Curr Opin Urol. 18:564–569. 2008. View Article : Google Scholar : PubMed/NCBI | |
Furth ME, Atala A and Van Dyke ME: Smart biomaterials design for tissue engineering and regenerative medicine. Biomaterials. 28:5068–5073. 2007. View Article : Google Scholar : PubMed/NCBI | |
Chan BP and Leong KW: Scaffolding in tissue engineering: General approaches and tissue-specific considerations. Eur Spine J. 17(Suppl 4): S467–S479. 2008. | |
Davis NF, Callanan A, McGuire BB, Mooney R, Flood HD and McGloughlin TM: Porcine extracellular matrix scaffolds in reconstructive urology: An ex vivo comparative study of their biomechanical properties. J Mech Behav Biomed Mater. 4:375–382. 2011. View Article : Google Scholar : PubMed/NCBI | |
Goldstein MB, Dearden LC and Gualtieri V: Regeneration of subtotally cystectomized bladder patched with omentum: An experimental study in rabbits. J Urol. 97:664–668. 1967.PubMed/NCBI | |
Andretto R, Gonzales J, Guidugli Netro J, de Miranda JF and Antunes AM: Experimental cystoplasty in dogs using preserved equine pericardium. AMB Rev Assoc Med Bras. 27:153–154. 1981.(In Portuguese). PubMed/NCBI | |
Nguyen DH and Mitchell ME: Gastric bladder reconstruction. Urol Clin North Am. 18:649–657. 1991.PubMed/NCBI | |
Draper JW and Stark RB: End results in the replacement of mucous membrane of the urinary bladder with thick-split grafts of skin. Surgery. 39:434–440. 1956.PubMed/NCBI | |
Atala A: Tissue engineering of human bladder. Br Med Bull. 97:81–104. 2011. View Article : Google Scholar : PubMed/NCBI | |
Dahms SE, Piechota HJ, Dahiya R, Lue TF and Tanagho EA: Composition and biomechanical properties of the bladder acellular matrix graft: Comparative analysis in rat, pig and human. Br J Urol. 82:411–419. 1998. View Article : Google Scholar : PubMed/NCBI | |
Mahfouz W, Elsalmy S, Corcos J and Fayed AS: Fundamentals of bladder tissue engineering. Afr J Urol. 19:51–57. 2013. View Article : Google Scholar | |
Yoo JJ, Meng J, Oberpenning F and Atala A: Bladder augmentation using allogenic bladder submucosa seeded with cells. Urology. 51:221–225. 1998. View Article : Google Scholar : PubMed/NCBI | |
Sutherland RS, Baskin LS, Hayward SW and Cunha GR: Regeneration of bladder urothelium, smooth muscle, blood vessels and nerves into an acellular tissue matrix. J Urol. 156:571–577. 1996. View Article : Google Scholar : PubMed/NCBI | |
Crapo PM, Gilbert TW and Badylak SF: An overview of tissue and whole organ decellularization processes. Biomaterials. 32:3233–3243. 2011. View Article : Google Scholar : PubMed/NCBI | |
Langer R and Vacanti JP: Tissue engineering. Science. 260:920–926. 1993. View Article : Google Scholar : PubMed/NCBI | |
Brehmer B, Rohrmann D, Becker C, Rau G and Jakse G: Different types of scaffolds for reconstruction of the urinary tract by tissue engineering. Urol Int. 78:23–29. 2007. View Article : Google Scholar : PubMed/NCBI | |
Kikuno N, Kawamoto K, Hirata H, et al: Nerve growth factor combined with vascular endothelial growth factor enhances regeneration of bladder acellular matrix graft in spinal cord injury-induced neurogenic rat bladder. BJU Int. 103:1424–1428. 2009. View Article : Google Scholar : PubMed/NCBI | |
Atala A: Recent developments in tissue engineering and regenerative medicine. Curr Opin Pediatr. 18:167–171. 2006. View Article : Google Scholar : PubMed/NCBI | |
Orabi H, Bouhout S, Morissette A, Rousseau A, Chabaud S and Bolduc S: Tissue engineering of urinary bladder and urethra: Advances from bench to patients. ScientificWorldJournal. 2013:1545642013.PubMed/NCBI | |
Brown AL, Farhat W, Merguerian PA, Wilson GJ, Khoury AE and Woodhouse KA: 22 week assessment of bladder acellular matrix as a bladder augmentation material in a porcine model. Biomaterials. 23:2179–2190. 2002. View Article : Google Scholar : PubMed/NCBI | |
Subramaniam R, Hinley J, Stahlschmidt J and Southgate J: Tissue engineering potential of urothelial cells from diseased bladders. J Urol. 186:2014–2020. 2011. View Article : Google Scholar : PubMed/NCBI | |
Chung SY: Bladder tissue-engineering: a new practical solution? Lancet. 367:1215–1216. 2006. View Article : Google Scholar : PubMed/NCBI | |
Atala A: Autologous cell transplantation for urologic reconstruction. J Urol. 159:2–3. 1998. View Article : Google Scholar : PubMed/NCBI | |
Matoka DJ and Cheng EY: Tissue engineering in urology. Can Urol Assoc J. 3:403–408. 2009.PubMed/NCBI | |
Bogash M, Kohler FP, Scott RH and Murphy JJ: Replacement of the urinary bladder by a plastic reservoir with mechanical valves. Surg Forum. 10:900–903. 1960.PubMed/NCBI | |
Bona AV and De Gresti A: Partial substitution of the bladder wall with teflon tissue. (Preliminary and experimental note on the impermeability and tolerance of the prosthesis). Minerva Urol. 18:43–47. 1966.(In Italian). PubMed/NCBI | |
Kelâmi A, Dustmann HO, Lüdtke-Handjery A, Cárcamo V and Herlld G: Experimental investigations of bladder regeneration using teflon-felt as a bladder wall substitute. J Urol. 104:693–698. 1970.PubMed/NCBI | |
Rohrmann D, Albrecht D, Hannappel J, Gerlach R, Schwarzkopp G and Lutzeyer W: Alloplastic replacement of the urinary bladder. J Urol. 156:2094–2097. 1996. View Article : Google Scholar : PubMed/NCBI | |
Baker SC, Rohman G, Southgate J and Cameron NR: The relationship between the mechanical properties and cell behaviour on PLGA and PCL scaffolds for bladder tissue engineering. Biomaterials. 30:1321–1328. 2009. View Article : Google Scholar : PubMed/NCBI | |
Pattison MA, Wurster S, Webster TJ and Haberstroh KM: Three dimensional, nano-structured PLGA scaffolds for bladder tissue replacement applications. Biomaterials. 26:2491–2500. 2005. View Article : Google Scholar : PubMed/NCBI | |
Pariente JL, Kim BS and Atala A: In vitro biocompatibility assessment of naturally derived and synthetic biomaterials using normal human urothelial cells. J Biomed Mater Res. 55:33–39. 2001. View Article : Google Scholar : PubMed/NCBI | |
Chen FM, Zhang M and Wu ZF: Toward delivery of multiple growth factors in tissue engineering. Biomaterials. 31:6279–6308. 2010. View Article : Google Scholar : PubMed/NCBI | |
Ulery BD, Nair LS and Laurencin CT: Biomedical applications of biodegradable polymers. J Polym Sci B Polym Phys. 49:832–864. 2011. View Article : Google Scholar : PubMed/NCBI | |
Harrington DA, Sharma AK, Erickson BA and Cheng EY: Bladder tissue engineering through nanotechnology. World J Urol. 26:315–322. 2008. View Article : Google Scholar : PubMed/NCBI | |
Elbert DL and Hubbell JA: Surface treatments of polymers for biocompatibilityAnnual Review of Materials Science. Vol 26. Annual Reviews. Palo Alto, CA: pp. 365–394. 1996 | |
Bohne AW and Urwiller KL: Experience with urinary bladder regeneration. J Urol. 77:725–732. 1957.PubMed/NCBI | |
Portilla Sanchez R, Blanco FL, Santamarina A, Casals Roa J, Mata J and Kaufman A: Vesical regeneration in the human after total cystectomy and implantation of a plastic mould. Br J Urol. 30:180–188. 1958. View Article : Google Scholar : PubMed/NCBI | |
Tsuji I, Kuroda K, Fujieda J, Shiraishi Y and Kunishima K: Clinical experiences of bladder reconstruction using preserved bladder and gelatin sponge bladder in the case of bladder cancer. J Urol. 98:91–92. 1967.PubMed/NCBI | |
Orikasa S and Tsuji I: Enlargement of contracted bladder by use of gelatin sponge bladder. J Urol. 104:107–110. 1970.PubMed/NCBI | |
Taguchi H, Ishizuka E and Saito K: Cystoplasty by regeneration of the bladder. J Urol. 118:752–756. 1977.PubMed/NCBI | |
Fujita K: The use of resin-sprayed thin paper for urinary bladder regeneration. Invest Urol. 15:355–357. 1978.PubMed/NCBI | |
Moon SJ, Kim DH, Jo JK, et al: Bladder reconstruction using bovine pericardium in a case of enterovesical fistula. Korean J Urol. 52:150–153. 2011. View Article : Google Scholar : PubMed/NCBI | |
Pokrywczynska M, Adamowicz J, Sharma AK and Drewa T: Human urinary bladder regeneration through tissue engineering - an analysis of 131 clinical cases. Exp Biol Med (Maywood). 239:264–271. 2014. View Article : Google Scholar : PubMed/NCBI | |
Shakhssalim N, Dehghan MM, Moghadasali R, Soltani MH, Shabani I and Soleimani M: Bladder tissue engineering using biocompatible nanofibrous electrospun constructs: Feasibility and safety investigation. Urol J. 9:410–419. 2012.PubMed/NCBI | |
Chun YW, Khang D, Haberstroh KM and Webster TJ: The role of polymer nanosurface roughness and submicron pores for improving bladder urothelial cell density and inhibiting calcium oxalate stone formation. Nanotechnology. 20:0851042009. View Article : Google Scholar : PubMed/NCBI | |
Probst M, Dahiya R, Carrier S and Tanagho EA: Reproduction of functional smooth muscle tissue and partial bladder replacement. Br J Urol. 79:505–515. 1997. View Article : Google Scholar : PubMed/NCBI | |
Oberpenning F, Meng J, Yoo JJ and Atala A: De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat Biotechnol. 17:149–155. 1999. View Article : Google Scholar : PubMed/NCBI | |
Aboushwareb T and Atala A: Stem cells in urology. Nat Clin Pract Urol. 5:621–631. 2008. View Article : Google Scholar : PubMed/NCBI | |
Lamba DA, Gust J and Reh TA: Transplantation of human embryonic stem cell derived photoreceptors restores some visual function in Crx-deficient mice. Cell Stem Cell. 4:73–79. 2009. View Article : Google Scholar : PubMed/NCBI | |
Yang D, Zhang ZJ, Oldenburg M, Ayala M and Zhang SC: Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells. 26:55–63. 2008. View Article : Google Scholar : PubMed/NCBI | |
Ballas CB, Zielske SP and Gerson SL: Adult bone marrow stem cells for cell and gene therapies: Implications for greater use. J Cell Biochem Suppl. 38(S38): 20–28. 2002.PubMed/NCBI | |
Gonzalez MA and Bernad A: Characteristics of adult stem cells. Adv Exp Med Biol. 741:103–120. 2012.PubMed/NCBI | |
Spradling A, Drummond-Barbosa D and Kai T: Stem cells find their niche. Nature. 414:98–104. 2001. View Article : Google Scholar : PubMed/NCBI | |
da Silva Meirelles L, Chagastelles PC and Nardi NB: Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 119:2204–2213. 2006. View Article : Google Scholar : PubMed/NCBI | |
Chung SY, Krivorov NP, Rausei V, et al: Bladder reconstitution with bone marrow derived stem cells seeded on small intestinal submucosa improves morphological and molecular composition. J Urol. 174:353–359. 2005. View Article : Google Scholar : PubMed/NCBI | |
Zuk PA, Zhu M, Ashjian P, et al: Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 13:4279–4295. 2002. View Article : Google Scholar : PubMed/NCBI | |
Drewa T: Using hair-follicle stem cells for urinary bladder-wall regeneration. Regen Med. 3:939–944. 2008. View Article : Google Scholar : PubMed/NCBI | |
de Coppi P, Bartsch G Jr..Siddiqui MM, et al: Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 25:100–106. 2007. View Article : Google Scholar : PubMed/NCBI | |
Mosquera A, Fernández JL, Campos A, Goyanes VJ, Ramiro-Díaz J and Gosálvez J: Simultaneous decrease of telomere length and telomerase activity with ageing of human amniotic fliuds cells. J Med Genet. 36:494–496. 1999.PubMed/NCBI | |
de Coppi P, Callegari A, Chiavegato A, et al: Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smooth muscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells. J Urol. 177:369–376. 2007. View Article : Google Scholar : PubMed/NCBI | |
Perin L, Sedrakyan S, Giuliani S, et al: Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One. 5:e93572010. View Article : Google Scholar : PubMed/NCBI | |
Moorefield EC, McKee EE, Solchaga L, Orlando G, Yoo JJ, Walker S, Furth ME and Bishop CE: Cloned, CD117 selected human amniotic fluid stem cells are capable of modulating the immune response. PLoS One. 6:e265352011. View Article : Google Scholar : PubMed/NCBI | |
Weber B, Emmert MY, Behr L, et al: Prenatally engineered autologous amniotic fluid stem cell-based heart valves in the fetal circulation. Biomaterials. 33:4031–4043. 2012. View Article : Google Scholar : PubMed/NCBI | |
Tian H, Bharadwaj S, Liu Y, Ma PX, Atala A and Zhang Y: Differentiation of human bone marrow mesenchymal stem cells into bladder cells: Potential for urological tissue engineering. Tissue Eng Part A. 16:1769–1779. 2010. View Article : Google Scholar : PubMed/NCBI | |
Fowler CJ, Griffiths D and de Groat WC: The neural control of micturition. Nat Rev Neurosci. 9:453–466. 2008. View Article : Google Scholar : PubMed/NCBI | |
Adamowicz J, Drewa T, Tworkiewicz J, Kloskowski T, Nowacki M and Pokrywczyńska M: Schwann cells - a new hope in tissue engineered urinary bladder innervation A method of cell isolation. Cent European J Urol. 64:87–89. 2011. View Article : Google Scholar : PubMed/NCBI | |
Hindryckx A and De Catte L: Prenatal diagnosis of congenital renal and urinary tract malformations. Facts Views Vis Obgyn. 3:165–174. 2011.PubMed/NCBI | |
Koh CJ and Atala A: Tissue engineering, stem cells, and cloning: Opportunities for regenerative medicine. J Am Soc Nephrol. 15:1113–1125. 2004. View Article : Google Scholar : PubMed/NCBI | |
Fuchs JR, Terada S, Ochoa ER, Vacanti JP and Fauza DO: Fetal tissue engineering: In utero tracheal augmentation in an ovine model. J Pediatr Surg. 37:1000–1006. 2002. View Article : Google Scholar : PubMed/NCBI | |
Fuchs JR, Hannouche D, Terada S, Vacanti JP and Fauza DO: Fetal tracheal augmentation with cartilage engineered from bone marrow-derived mesenchymal progenitor cells. J Pediatr Surg. 38:984–987. 2003. View Article : Google Scholar : PubMed/NCBI |